Cardinal Health sells $1 billion in notes to help fund Solaris Health acquisition
Cardinal Health completed a $1 billion public offering of two note series, $600 million due 2030 and $400 million due 2035, with proceeds intended to fund part of the price of its proposed Solaris Health acquisition. If the deal is not completed by the End Date, or the company decides not to pursue it, the notes must be redeemed at 101% of principal plus accrued interest.
Key points
- $600 million of 4.500% notes due 2030 and $400 million of 5.150% notes due 2035 were sold on August 27, 2025.
- Net proceeds are intended to fund part of the consideration and fees for the proposed Solaris Health acquisition.
- The acquisition must close by the later of August 12, 2026 or a later extended date, or the notes face special mandatory redemption at 101% of principal plus accrued interest.
- Proceeds will not be placed in escrow and no security interest is required.
The filing
Written by AI on Nov 8, 2026, 1:42 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on August 27, 2025.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.